Page 22 - AN-2-2

Advanced Neurology A novel approach to mitigate muscle atrophy in GBS

M-gammaglobinemia, and skin changes [POEMS]). The 268: 2402–2419.
current research in omega-3 supplementation in relation https://doi.org//10.1007/s00415-020-09742-2
to nerve and muscle health has shown intriguing promise;
however, future investigations must explore this potential 3. Pithadia AB, Kakadia N, (2010), Guillain-Barré syndrome
lest it remain theoretical. (GBS). Pharmacol Rep, 62: 220–232.
https://doi.org//10.1016/s1734-1140(10)70261-9
Acknowledgments
4. Mirian A, Nicolle MW, Budhram A, (2021), Guillain-Barré
We would like to thank Chris McGlory for his contribution syndrome. Can Med Assoc J, 193: E378–E378.
in the direction of this paper. https://doi.org//10.1503/cmaj.202710
Funding 5. Florian IA, Lupan I, Sur L, et al., (2021), To be, or not to be…
Guillain-Barré syndrome. Autoimmun Rev, 20: 102983.
None.
https://doi.org//10.1016/j.autrev.2021.102983
Conflict of interest 6. Fokke C, van den Berg B, Drenthen J, et al., (2014), Diagnosis

All authors deny any conflicts or competing interests of Guillain-Barré syndrome and validation of Brighton
with any institutes, organizations or agencies that might criteria. Brain, 137: 33–43.
influence the integrity of results or objective interpretation https://doi.org//10.1093/BRAIN/AWT285
of this submission. 7. van den Berg B, Walgaard C, Drenthen J, et al., (2014),

Author contributions Guillain-Barré syndrome: Pathogenesis, diagnosis,
treatment and prognosis. Nat Rev Neurol, 10: 469–482.
Conceptualization: Kevin Cheung, Matti D. Allen https://doi.org/10.1038/nrneurol.2014.121
Visualization: Kevin Cheung
Writing – original draft: Kevin Cheung 8. Querol L, Lleixà C, (2021), Novel immunological and
Writing – review & editing: Sussan Askari, Matti D. Allen therapeutic insights in Guillain-Barré syndrome and CIDP.
Neurotherapeutics, 18: 2222–2235.
Ethics approval and consent to participate https://doi.org/10.1007/s13311-021-01117-3
Not applicable. 9. Rajabally YA, Uncini A, (2012), Outcome and its predictors
in Guillaine-Barré syndrome. J Neurol Neurosurg Psychiatry,
Consent for publication 83: 711–718.
Not applicable. https://doi.org/10.1136/jnnp-2011-301882

Availability of data 10. Harbo T, Markvardsen LK, Hellfritzsch MB, et al., (2019),
Neuromuscular electrical stimulation in early rehabilitation
Not applicable. of Guillain-Barré syndrome: A pilot study. Muscle Nerve,
59: 481–484.
Further disclosure
https://doi.org/10.1002/MUS.26396
A single essay version of this article was previously 11. Albers JW, Donofrio PD, McGonagle TK, (1985), Sequential
submitted to the 2022 Canadian Association of Physical electrodiagnostic abnormalities in acute inflammatory
Medicine & Rehabilitation Medical Student Essay Contest demyelinating polyradiculoneuropathy. Muscle Nerve,
on April 1, 2022. There would be approximately 70% 8: 528–539.
overlap in content with this published article. The scope
of the essay would have been identical to this article. To https://doi.org/10.1002/MUS.880080609
the best of the author’s knowledge, this essay has remained 12. Van Den Berg B, Storm EF, Garssen MJ, et al., (2018), Clinical
unpublished. outcome of Guillain-Barré syndrome after prolonged
mechanical ventilation. J Neurol Neurosurg Psychiatry,
References 89: 949–954.
1. Willison HJ, Jacobs BC, van Doorn PA, (2016), Guillain- https://doi.org/10.1136/JNNP-2018-317968
Barré syndrome. Lancet, 388: 717–727. 13. Ferguson EJ, Seigel JW, McGlory C, (2021), Omega-3 fatty
https://doi.org//10.1016/S0140-6736(16)00339-1 acids and human skeletal muscle. Curr Opin Clin Nutr
Metab Care, 24: 114–119.
2. Shang P, Zhu M, Wang Y, et al., (2021), Axonal variants
of Guillain-Barré syndrome: An update. J Neurol, https://doi.org/10.1097/MCO.0000000000000723

Volume 2 Issue 2 (2023) 8 https://doi.org/10.36922/an.280